NEWS

Publications

Search

Search by category, name, and more

Sort by Category

Sort by Type

Find Out More

For more information or to get involved in our research, fill out the contact form on our website! We look forward to hearing from you!

Recent Publications

CC16 drives VLA-2-dependent SPLUNC1 expression

Circulating CC16 and Asthma: a Population-Based, Multi-Cohort Study from Early Childhood Through Adult Life

β-Arrestin-biased proteinase-activated receptor-2 antagonist C781 limits allergen-induced airway hyperresponsiveness and inflammation

CC16 Binding to α4β1 Integrin (VLA-4) Protects Against Mycoplasma pneumoniae Infection

Revolutionizing Treatment for Obstructive Lung Diseases

Sitemap

Become an Investor

Email in*******@as******.com today for more information, or visit our website to stay updated on Aspiro Therapeutics’ growth.

in**@as******.com
760.659.0779
Tucson, AZ 85704

© 2024 Aspiro Therapeutics. All Rights Reserved.